Literature DB >> 16247607

Inhibition of erythrocyte "apoptosis" by catecholamines.

Philipp A Lang1, Daniela S Kempe, Ahmad Akel, Barbara A Klarl, Kerstin Eisele, Marlies Podolski, Tobias Hermle, Olivier M Niemoeller, Philipp Attanasio, Stephan M Huber, Thomas Wieder, Florian Lang, Christophe Duranton.   

Abstract

Osmotic shock, oxidative stress and Cl- removal activate a non-selective Ca2+-permeable cation conductance in human erythrocytes. The entry of Ca2+ leads to activation of a scramblase with subsequent exposure of phosphatidylserine at the cell surface. Phosphatidylserine mediates binding to phosphatidylserine receptors on macrophages which engulf and degrade phosphatidylserine exposing cells. Moreover, phosphatidylserine exposure may lead to adherence of erythrocytes to the vascular wall. In the present study, we explored whether activation of the non-selective cation conductance and subsequent phosphatidylserine exposure might be influenced by catecholamines. Phosphatidylserine exposure has been determined by FITC-annexin V binding while cell volume was estimated from forward scatter in FACS analysis. Removal of Cl- enhanced annexin binding and decreased forward scatter, an effect significantly blunted by the beta agonist isoproterenol (IC50 approx. 1 microM). Fluo-3 fluorescence measurements revealed an increase of cytosolic Ca2+ activity following Cl- removal, an effect again significantly blunted by isoproterenol exposure (10 microM). Whole-cell patch-clamp experiments performed in Cl- free bath solution indeed disclosed a time-dependent inactivation of a non-selective cation conductance following isoproterenol exposure (10 microM). Phenylephrine (IC50<10 microM), dobutamine (IC50 approx. 1 microM) and dopamine (IC50 approx. 3 microM) similarly inhibited the effect of Cl- removal on annexin binding and forward scatter. In conclusion, several catecholamines inhibit the Cl- removal-activated Ca2+ entry into erythrocytes, thus preventing increase of cytosolic Ca2+ activity, subsequent cell shrinkage and activation of erythrocyte scramblase. The catecholamines thus counteract erythrocyte phosphatidylserine exposure and subsequent clearance of erythrocytes from circulating blood.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247607     DOI: 10.1007/s00210-005-0009-2

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  60 in total

1.  Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria.

Authors:  D Bratosin; J Estaquier; F Petit; D Arnoult; B Quatannens; J P Tissier; C Slomianny; C Sartiaux; C Alonso; J J Huart; J Montreuil; J C Ameisen
Journal:  Cell Death Differ       Date:  2001-12       Impact factor: 15.828

2.  Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis.

Authors:  C P Berg; I H Engels; A Rothbart; K Lauber; A Renz; S F Schlosser; K Schulze-Osthoff; S Wesselborg
Journal:  Cell Death Differ       Date:  2001-12       Impact factor: 15.828

3.  Hypertonicity activates nonselective cation channels in mouse cortical collecting duct cells.

Authors:  T Volk; E Frömter; C Korbmacher
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

4.  Plasma dopamine concentration and effects of low dopamine doses on urinary output after major vascular surgery.

Authors:  V Pavoni; M Verri; L Ferraro; C A Volta; L Paparella; M Capuzzo; L Pavanelli; C Buccoliero; L Beani; R Alvisi; G Gritti
Journal:  Kidney Int Suppl       Date:  1998-05       Impact factor: 10.545

5.  Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells.

Authors:  Dina A Andrews; Lu Yang; Philip S Low
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin.

Authors:  A B Manodori; G A Barabino; B H Lubin; F A Kuypers
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

7.  Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1.

Authors:  Quansheng Zhou; Ji Zhao; Therese Wiedmer; Peter J Sims
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

8.  Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia.

Authors:  F E Boas; L Forman; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

9.  Splenic sequestration and ineffective erythropoiesis in hemoglobin E-beta-thalassemia disease.

Authors:  F B Ruymann; L A Popejoy; R B Brouillard
Journal:  Pediatr Res       Date:  1978-10       Impact factor: 3.756

10.  Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency.

Authors:  L Corash; S Spielberg; C Bartsocas; L Boxer; R Steinherz; M Sheetz; M Egan; J Schlessleman; J D Schulman
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

View more
  13 in total

1.  Induction of eryptosis by cyclosporine.

Authors:  Olivier M Niemoeller; Ahmad Akel; Philipp A Lang; Philipp Attanasio; Daniela S Kempe; Tobias Hermle; Malgorzata Sobiesiak; Thomas Wieder; Florian Lang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-22       Impact factor: 3.000

2.  Phosphatidylserine externalization and membrane blebbing are involved in the nonclassical export of FGF1.

Authors:  Aleksandr Kirov; Huda Al-Hashimi; Phil Solomon; Courtney Mazur; Philip E Thorpe; Peter J Sims; Francesca Tarantini; Thallapuranam K Suresh Kumar; Igor Prudovsky
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

3.  Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid.

Authors:  Ravi S Kasinathan; Michael Föller; Saisudha Koka; Stephan M Huber; Florian Lang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-19       Impact factor: 3.000

4.  Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.

Authors:  C K Kontos; I N Papadopoulos; E G Fragoulis; A Scorilas
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

Review 5.  Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.

Authors:  Elisabeth Lang; Florian Lang
Journal:  Biomed Res Int       Date:  2015-03-04       Impact factor: 3.411

Review 6.  Eryptosis: An Erythrocyte's Suicidal Type of Cell Death.

Authors:  Lisa Repsold; Anna Margaretha Joubert
Journal:  Biomed Res Int       Date:  2018-01-03       Impact factor: 3.411

7.  L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.

Authors:  Panagiota-Aikaterini Geomela; Christos K Kontos; Ioannis Yiotakis; Emmanuel G Fragoulis; Andreas Scorilas
Journal:  BMC Cancer       Date:  2012-10-20       Impact factor: 4.430

8.  Adenosine protects against suicidal erythrocyte death.

Authors:  Olivier M Niemoeller; Peter J Bentzen; Elisabeth Lang; Florian Lang
Journal:  Pflugers Arch       Date:  2007-02-07       Impact factor: 4.458

9.  Altered membrane structure and surface potential in homozygous hemoglobin C erythrocytes.

Authors:  Fuyuki Tokumasu; Glenn A Nardone; Graciela R Ostera; Rick M Fairhurst; Steven D Beaudry; Eri Hayakawa; James A Dvorak
Journal:  PLoS One       Date:  2009-06-08       Impact factor: 3.240

10.  Blunted apoptosis of erythrocytes in mice deficient in the heterotrimeric G-protein subunit Gαi2.

Authors:  Rosi Bissinger; Elisabeth Lang; Mehrdad Ghashghaeinia; Yogesh Singh; Christine Zelenak; Birgit Fehrenbacher; Sabina Honisch; Hong Chen; Hajar Fakhri; Anja T Umbach; Guilai Liu; Rexhep Rexhepaj; Guoxing Liu; Martin Schaller; Andreas F Mack; Adrian Lupescu; Lutz Birnbaumer; Florian Lang; Syed M Qadri
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.